When we performed the GSEA in the HLRCC patient cohort, we observed MYC and E2F target signatures as the top up-regulated ones, together with a significant up-regulation of the EMT signature (Fig. 4B). Here, MYC is linked to hereditary leiomyomatosis and renal cell cancer.